Sanofi SNY
NASDAQ SNY
$42.72 -0.13 (-0.30%)
As of: Sep 10, 2026 · 3:59 PM EDT

Sanofi (SNY) Total Liabilities (2009 - 2026)

Sanofi's (SNY) quarterly Total Liabilities came in at $69.2 billion in Q2 2026, up 11.72% year-over-year from $61.9 billion in Q2 2025, and up 394.98% quarter-over-quarter from $14.0 billion in Q4 2025.

Analysis

Sanofi (SNY) Total Liabilities (2009 - 2026) Analysis & Trends

Sanofi has disclosed Total Liabilities across 18 years of filings, most recently posting $69.2 billion for Q2 2026.

  • In Q2 2026, Total Liabilities rose 11.72% year-over-year to $69.2 billion; the TTM figure through Jun 2026 stood at $69.2 billion (up 11.72% YoY), while the FY2025 annual figure was $14.0 billion, down 76.51% from the prior year.
  • Total Liabilities came in at $69.2 billion for Q2 2026 at Sanofi, up from $14.0 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $69.2 billion in Q2 2026 to a low of $14.0 billion in Q4 2025.
  • Average Total Liabilities over 5 years is $53.8 billion, with a median of $57.1 billion recorded in 2023.
  • Year-over-year, Total Liabilities plunged 76.2% in 2025 and rose 11.72% in 2026.
  • Over 5 years, Total Liabilities stood at $52.6 billion in 2022, then gained by 6.57% to $56.1 billion in 2023, then grew by 4.71% to $58.7 billion in 2024, then sank by 76.2% to $14.0 billion in 2025, then jumped by 394.98% to $69.2 billion in 2026.
  • Per Business Quant data, the three most recent Total Liabilities figures were $69.2 billion in Q2 2026, $14.0 billion in Q4 2025, and $61.9 billion in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 116.09 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 141.05 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 23.74 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 80.09 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 115.64 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 69.15 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 1.72 Bn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 1.53 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 819.80 Mn
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn 1.67 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.15 Bn
Dec 31, 2025 13.97 Bn
Jun 30, 2025 61.90 Bn
Dec 31, 2024 58.71 Bn
Jun 30, 2024 61.12 Bn
Dec 31, 2023 56.07 Bn
Jun 30, 2023 57.07 Bn
Dec 31, 2022 52.61 Bn
Jun 30, 2022 53.91 Bn
Dec 31, 2021 58.58 Bn
Jun 30, 2021 59.11 Bn
Dec 31, 2020 61.00 Bn
Jun 30, 2020 57.64 Bn
Dec 31, 2019 3.09 Bn
Jun 30, 2019 60.71 Bn
Dec 31, 2018 2.32 Bn
Sep 30, 2018 458.27 Mn
Mar 31, 2018 65.62 Bn
Dec 31, 2017 2.74 Bn
Jun 30, 2017 48.47 Bn